Metastatic Melanoma
Showing NaN - NaN of 22
Metastatic Melanoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Hodgkin Lymphoma Trial in
Active, not recruiting
- Metastatic Melanoma
- +22 more
- Ipilimumab
- +3 more
-
Birmingham, Alabama
- +24 more
Jan 19, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +20 more
- Ipilimumab
- +3 more
-
Tampa, Florida
- +6 more
Jan 13, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Digestive System Carcinoma Trial in United
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +12 more
- Memantine
- +4 more
-
Tucson, Arizona
- +60 more
Jan 11, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib
- +4 more
-
Phoenix, Arizona
- +48 more
Jan 3, 2023
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- Metastatic Melanoma
- Dabrafenib Mesylate
- +2 more
-
Atlanta, Georgia
- +6 more
Nov 30, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Biospecimen Collection
- +9 more
-
Birmingham, Alabama
- +848 more
Aug 24, 2022
Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in
Recruiting
- Advanced Differentiated Thyroid Gland Carcinoma
- +102 more
- Cabozantinib S-malate
- Nivolumab
-
Chicago, Illinois
- +2 more
Apr 5, 2022
Metastatic Melanoma Trial in Chicago (Photoimmunotherapy)
Terminated
- Metastatic Melanoma
- Photoimmunotherapy
-
Chicago, IllinoisNorthwestern University Feinberg School of Medicine, Department
Dec 1, 2021
Acral Lentiginous Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Cutaneous Melanoma Trial in United States
Recruiting
- Acral Lentiginous Melanoma
- +6 more
- Binimetinib
- +3 more
-
Birmingham, Alabama
- +309 more
Nov 8, 2021
Metastatic Melanoma Trial in Worldwide (MORAb-004 (mAb))
Completed
- Metastatic Melanoma
- MORAb-004 (monoclonal antibody)
-
Scottsdale, Arizona
- +28 more
Aug 6, 2021
Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))
Terminated
- Metastatic Melanoma
- Head Neck Cancer
- SD-101(1)
- +3 more
-
Birmingham, Alabama
- +46 more
Jul 12, 2021
Metastatic Melanoma, Mucosal Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (biological, other,
Completed
- Metastatic Melanoma
- +4 more
- Bevacizumab
- +4 more
-
San Francisco, California
- +12 more
Jan 7, 2020
Advanced Melanoma, Metastatic Melanoma Trial in Netherlands, Spain, United States (Nivolumab, Ipilimumab)
Completed
- Advanced Melanoma
- Metastatic Melanoma
- Nivolumab
- Ipilimumab
-
Los Angeles, California
- +13 more
Nov 14, 2019
Treatment Patterns and Clinical Response in Malignancy
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
-
Tucson, Arizona
- +44 more
Jun 11, 2019
Metastatic Melanoma Trial in Chicago (Calcitriol, Temozolomide)
Completed
- Metastatic Melanoma
- Calcitriol
- Temozolomide
-
Chicago, IllinoisRobert H. Lurie Comprehensive Cancer Center at Northwestern Univ
May 23, 2019
Metastatic Melanoma, Recurrent Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in United States (Aldesleukin, Laboratory
Completed
- Metastatic Melanoma
- +6 more
- Aldesleukin
- +2 more
-
Duarte, California
- +20 more
May 9, 2019
Metastatic Melanoma Trial in United States (VCL-IM01 (encoding IL-2) with Electroporation)
Completed
- Metastatic Melanoma
- VCL-IM01 (encoding IL-2) with Electroporation
-
Mobile, Alabama
- +3 more
Feb 25, 2019
Metastatic Melanoma, Cutaneous Melanoma Trial in Chicago, Pittsburgh (HDI, KW2871)
Completed
- Metastatic Melanoma
- Cutaneous Melanoma
-
Chicago, Illinois
- +1 more
Feb 19, 2018
Metastatic Melanoma Trial in Worldwide (Allovectin-7®, Dacarbazine (DTIC), Temozolomide (TMZ))
Completed
- Metastatic Melanoma
- Allovectin-7®
- +2 more
-
Tucson, Arizona
- +87 more
Sep 11, 2013
Metastatic Melanoma Trial in Chicago (MAGE-3/Melan-A/gp100/NA PBMC, rhIL-12 (drug), MAGE-3/Melan-A/gp100/NA17 Peptide-pulsed
Completed
- Metastatic Melanoma
- MAGE-3/Melan-A/gp100/NA PBMC, rhIL-12 (drug)
- MAGE-3/Melan-A/gp100/NA17 Peptide-pulsed autologous PBMC, rhIL-12 with IL-2
-
Chicago, IllinoisThe University of Chicago
Sep 4, 2013